News & Updates

Triple therapy improves health status of COPD patients in real-world setting

30 Nov 2024 by

Treatment with budesonide/glycopyrronium/formoterol (BGF), a triple therapy delivered via metered-dose inhaler (MDI), improves health status in Chinese patients with chronic obstructive pulmonary disease (COPD), based on real-world data presented at APSR 2024.

Triple therapy improves health status of COPD patients in real-world setting

30 Nov 2024

Meropenem-vaborbactam on par with ceftazidime-avibactam for survival in CRE infections, with an edge against resistance emergence

30 Nov 2024 by

The likelihood of survival at 30 days among patients with CRE infections is similar for those who receive ceftazidime-avibactam or meropenem-vaborbactam. However, recurrent infections and the emergence of resistance are observed less frequently with the latter carbapenem/BLI combination, as suggested by a prospective observational study presented at IDWeek 2024

Meropenem-vaborbactam on par with ceftazidime-avibactam for survival in CRE infections, with an edge against resistance emergence

30 Nov 2024

Widespread “test-and-treat” practices raise concerns over H. pylori management in children

29 Nov 2024 by

For the screening and diagnosis of paediatric Helicobacter pylori infection at a tertiary centre in Singapore, endoscopies are often skipped in favour of a “test-and-treat” approach based on noninvasive testing, a practice that deviates from recommended protocols.

Widespread “test-and-treat” practices raise concerns over H. pylori management in children

29 Nov 2024

CPET is most analysed tool for assessing functionality before surgery

29 Nov 2024

Among the many tools being used to assess functional capacity prior to elective noncardiac surgery, cardiopulmonary exercise testing (CPET) is the most studied, followed by field walking tests, according to a study. Moreover, most research also focuses on only one aspect of validity.

CPET is most analysed tool for assessing functionality before surgery

29 Nov 2024

Good glycaemic control helps slow brain ageing

29 Nov 2024 by

Improved glycaemic control is a big contributor to the neuroprotective effects of Mediterranean (MED) and green-MED diets on brain age, a study has shown. In addition, polyphenols-rich diet components such as Mankai and green tea help prevent brain ageing.

Good glycaemic control helps slow brain ageing

29 Nov 2024

Weight loss interventions ease symptoms, improve biomarkers of PCOS

29 Nov 2024

Weight loss interventions help improve some features of polycystic ovary syndrome (PCOS), making it a potential treatment option for women with PCOS, suggests a study.

Weight loss interventions ease symptoms, improve biomarkers of PCOS

29 Nov 2024

Flu shots reduce spread of infection within households

29 Nov 2024

Influenza vaccination appears to mitigate the risk of secondary infections among unvaccinated household contacts, according to a study.

Flu shots reduce spread of infection within households

29 Nov 2024

Ropeginterferon alfa-2b supports a shift in polycythaemia vera treatment

29 Nov 2024

Professor Jean-Jacques Kiladjian, Professor of Clinical Pharmacology, Consultant Haematologist, and head of the Clinical Investigation Centre of Hôpital Saint-Louis & Université Paris Cité in Paris, France, discusses the drawbacks of conventional therapy for PV, and how ropeginterferon alfa-2b may support a shift in treatment.

Ropeginterferon alfa-2b supports a shift in polycythaemia vera treatment

29 Nov 2024

The role of ropeginterferon alfa-2b in the management of polycythaemia vera in SG

29 Nov 2024

MIMS Oncology explores the current landscape of polycythaemia vera management in Singapore and the role of the newly launched ropeginterferon alfa-2b in improving patient outcomes. During an interview, Dr Dawn Mya, a leading haematologist practicing at Parkway Cancer Centre, Singapore, provides expert insights into the therapeutic potential of this novel treatment.

The role of ropeginterferon alfa-2b in the management of polycythaemia vera in SG

29 Nov 2024

Sex-based gap in liver transplant allocation narrowed with MELD 3.0

28 Nov 2024 by

More women are now being included in liver transplant waitlist and undergoing the procedure following the adoption of the updated Model for End-Stage Liver Disease (MELD)—MELD 3.0—with mortality and transplant rates nearly matching those observed in men, according to a retrospective study conducted in the US.

Sex-based gap in liver transplant allocation narrowed with MELD 3.0

28 Nov 2024

News & Updates

Filter by Specialty:

Specialty:

Triple therapy improves health status of COPD patients in real-world setting

Triple therapy improves health status of COPD patients in real-world setting

Meropenem-vaborbactam on par with ceftazidime-avibactam for survival in CRE infections, with an edge against resistance emergence

Meropenem-vaborbactam on par with ceftazidime-avibactam for survival in CRE infections, with an edge against resistance emergence

Widespread “test-and-treat” practices raise concerns over H. pylori management in children

Widespread “test-and-treat” practices raise concerns over H. pylori management in children

CPET is most analysed tool for assessing functionality before surgery

CPET is most analysed tool for assessing functionality before surgery

Good glycaemic control helps slow brain ageing

Good glycaemic control helps slow brain ageing

Weight loss interventions ease symptoms, improve biomarkers of PCOS

Weight loss interventions ease symptoms, improve biomarkers of PCOS

Flu shots reduce spread of infection within households

Flu shots reduce spread of infection within households

Ropeginterferon alfa-2b supports a shift in polycythaemia vera treatment

Ropeginterferon alfa-2b supports a shift in polycythaemia vera treatment

The role of ropeginterferon alfa-2b in the management of polycythaemia vera in SG

The role of ropeginterferon alfa-2b in the management of polycythaemia vera in SG

Sex-based gap in liver transplant allocation narrowed with MELD 3.0

Sex-based gap in liver transplant allocation narrowed with MELD 3.0